tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Stock Investors

802 Followers
Based on 769,002 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GYRE
On average, investors allocate 0.00% of their portfolios to GYRE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,002 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GYRE

2.0%
Last 7
Days
6.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GYRE, out of 769,002 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GYRE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,689 investors who made their portfolios public
The table shows changes in GYRE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GYRE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.47%
-1.55%
+0.62%
38.05B
Consumer Cyclical
Viking Therapeutics
4.53%
+0.19%
+7.08%
5.74B
Healthcare
Plug Power
5.20%
-1.18%
-0.87%
1.75B
Industrials
Li Auto
5.57%
-1.96%
-4.55%
23.18B
Consumer Cyclical
XPeng, Inc. ADR
5.51%
-1.45%
-1.51%
12.63B
Consumer Cyclical
Block
4.46%
+0.68%
+2.99%
56.87B
Technology
Nio
9.70%
-0.77%
+0.43%
10.07B
Consumer Cyclical
Bristol-Myers Squibb
3.56%
-0.57%
-1.16%
118.10B
Healthcare
Carnival
6.44%
-0.18%
+7.66%
31.45B
Consumer Cyclical
Lucid Group
5.79%
-1.34%
+1.51%
6.32B
Consumer Cyclical
Based on the activity of 769,002 active portfolios
Open your Smart Portfolio

GYRE Investor Analysis

GYRE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.9%
of GYRE holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
GYRE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.7%
of GYRE holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
GYRE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
35.4%
of GYRE holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of GYRE stock investors
See who invests in GYRE according to age group and performance.

FAQ

How many retail Investors hold GYRE?
<0.1% of TipRanks' retail investors hold GYRE in their portfolios.
    What is GYRE Investor Sentiment?
    GYRE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GYRE in the last 7 days?
      ▼ 2.0% of TipRanks' retail investors changed their holding of GYRE in the last 7 days.
        What percentage of retail investors changed their holding of GYRE in the last 30 days?
        ▼ 6.2% of TipRanks' retail investors changed their holding of GYRE in the last 30 days.
          What is the average age of retail investors who hold GYRE?
          The average age of GYRE Holders is between 35–55.
            What other stocks have GYRE investors also bought?
            GYRE Investors also bought DKNG, VKTX, PLUG, LI, XPEV, SQ, NIO, BMY, CCL, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CRMDCormedix
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis